GENPACT LIMITED closed at $41.10 on Nov 5, up 0.78%, 15.3% below its 52-week closing high. Volume of 2.0M shares was 1.05× its 20-day average (close to normal).
Split-adjusted performance: +22.1% over one month, +19.2% over six months, +6.9% over one year.
In the quarter ended Jun 30, 2026, revenue was $1.34B, up 7.1% from a year earlier, with a net margin of 10.8%.
Short interest was 11.1M shares at the Oct 15 settlement (6.7% of float, 6.1 days to cover).